If you have CKD and high blood pressure, you may be eligible for this research study. The BaxDuo-Arctic study is being conducted to determine if a combination investigational treatment of baxdrostat with dapagliflozin (BaxDuo) may work better at lowering your blood pressure and slowing CKD progression than dapagliflozin alone.

Qualified Participants: 

• 18 years and older
• Have CKD and high blood pressure with medical records
• Have not received any dialysis treatment for at least 3 months

Qualified Participants May: 

• Receive study-related exams at no cost
• Receive study-related medication at no cost
• Receive compensation for time and travel

Please call 305-888-0410 OR apply below to learn more about the benefits and details of this trial!